PredictImmune
Before co-founding Parkwalk in 2009, Alastair was a Partner of Lazard LLP, Director of BNP and a Founder Partner of Ark Securities. He has analyzed and advised both private and public companies on strategy, development, fund-raising and exits. He oversees the investment process at Parkwalk and he sits on various portfolio company Boards including Congenica, Mogrify, Petmedix, Phoremost, Predictimmune, and Mirriad.
This person is not in the org chart
This person is not in any offices
PredictImmune
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.